Wird geladen...
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: Past, present, and future
Glucagon-like peptide-1 (GLP-1)–based therapy improves glycaemic control through multiple mechanisms, with a low risk of hypoglycaemia and the additional benefit of clinically relevant weight loss. Since Starling and Bayliss first proposed the existence of intestinal secretions that stimulate the pa...
Gespeichert in:
| Veröffentlicht in: | Indian J Endocrinol Metab |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Medknow Publications & Media Pvt Ltd
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4792029/ https://ncbi.nlm.nih.gov/pubmed/27042424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.176351 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|